PODD Profile
Insulet Corporation develops, manufactures, and markets insulin delivery systems designed for individuals with insulin-dependent diabetes. The company’s flagship product, the Omnipod System, includes a self-adhesive, tubeless device that can be worn on the body for up to three days, along with a wireless handheld personal diabetes manager. This innovative system simplifies insulin delivery, offering a discreet and convenient solution for diabetes management.
Insulet distributes its products primarily through independent distributors and pharmacy channels, ensuring wide accessibility for users. The company also engages in direct sales in key markets, including the United States, Canada, Europe, the Middle East, and Australia. This broad distribution network supports Insulet’s mission to improve the quality of life for people living with diabetes by providing cutting-edge, user-friendly insulin delivery systems.
Founded in 2000 and headquartered in Acton, Massachusetts, Insulet Corporation has established itself as a leader in the diabetes care industry. The company’s commitment to innovation and patient-centric design is evident in its continuous development of advanced diabetes management solutions. Insulet’s focus on expanding its product offerings and geographical reach underscores its dedication to addressing the global diabetes epidemic.
Beyond its core product, the Omnipod System, Insulet is actively involved in research and development to enhance its technology and introduce new solutions for diabetes care. The company’s strategic partnerships and collaborations with healthcare providers and technology firms further bolster its position in the market. Insulet’s vision is to lead the way in transforming diabetes management, making it easier and more effective for patients around the world.
|
